|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 1126-1150 out of 1216. << < 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>
Public Release: 14-Feb-2013
 Cell Host & MicrobeDiscovery in HIV may solve efficiency problems for gene therapy Case Western Reserve researchers pinpoint RNA element missing from viral vectors. Contact: Jessica Studeny
Public Release: 14-Feb-2013
American Journal of Public HealthStudy shows alcohol consumption is a leading preventable cause of cancer death in the US Researchers from the Boston University School of Medicine and Boston University School of Public Health have shown that alcohol is a major contributor to cancer deaths and years of potential life lost. These findings, published in the Apr. 2013 issue of the American Journal of Public Health, also show that reducing alcohol consumption is an important cancer prevention strategy as alcohol is a known carcinogen even when consumed in small quantities. Contact: Gina DiGravio
Public Release: 14-Feb-2013
Journal of the National Cancer InstituteThe role of radical prostatectomy in patients with prostate cancer Even in the presence of screening, there is benefit to radical prostatectomy (RP) in prostate cancer patients, however, the benefit is limited to a subgroup of patients and can take years to become evident according to a study published Feb. 14 in the Journal of the National Cancer Institute. Contact: Zachary Rathner
Public Release: 14-Feb-2013
Lancet OncologyResearchers discover breakthrough in ovarian cancer Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib. Contact: Lynne Reaves
Public Release: 14-Feb-2013
PLOS ONECombo of Avastin, second drug shows promise fighting brain cancer, Mayo Clinic finds The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens. 
National Institutes of Health
Contact: Kevin Punsky
Public Release: 14-Feb-2013
CellStudy tracks leukemia's genetic evolution, may help predict disease course, tailor care A study led by Dana-Farber Cancer Institute and the Broad Institute researchers shows how gene mutations shift and evolve over time in chronic lymphocytic leukemia (CLL). This evolution, they report, holds the key to understanding why CLL often recurs after treatment and helps explain why patients with a seemingly similar disease often don't derive the same benefit from therapy and why therapy itself may speed the recurrence of the disease.
National Institutes of Health, Melton and Rosenbach Funds, ASH, Blavatnik Family Foundation, ACS, Damon Runyon Cancer Research Foundation, American Association for Cancer Research
Contact: Teresa Herbert
Public Release: 14-Feb-2013
Clinical Cancer ResearchHopkins scientists create method to personalize chemotherapy drug selection In laboratory studies, scientists at the Johns Hopkins Kimmel Cancer Center have developed a way to personalize chemotherapy drug selection for cancer patients by using cell lines created from their own tumors.
National Institutes of Health, Sol Goldman Pancreatic Cancer Research
Contact: Vanessa Wasta
Public Release: 14-Feb-2013
BloodRisk of leukemia after cancer chemotherapy persists While advancements in cancer treatment over the last several decades have improved patient survival rates for certain cancers, some patients remain at risk of developing treatment-related leukemia, according to results of a study published online today in Blood, the Journal of the American Society of Hematology. Contact: Andrea Slesinski
Public Release: 14-Feb-2013
Aging CellLow-protein diet slows Alzheimer's in mice Mice with many of the pathologies of Alzheimer's disease showed fewer signs of the disease when given a protein-restricted diet supplemented with specific amino acids every other week for four months.
National Institutes of Health
Contact: Robert Perkins
Public Release: 14-Feb-2013
Journal of Biological ChemistryIndian plant could play key role in death of cancer cells Scientists at the Georgia Regents University Cancer Center have identified an Indian plant, used for centuries to treat inflammation, fever and malaria, that could help kill cancer cells. Contact: Danielle Moores
Public Release: 13-Feb-2013
PLOS ONECalifornia's Tobacco Control Program generates huge health care savings, UCSF study shows Over a span of nearly 20 years, California's tobacco control program cost $2.4 billion and reduced health care costs by $134 billion, according to a new study by UC San Francisco.
NIH/National Cancer Institute, TRDRP
Contact: Elizabeth Fernandez
Public Release: 13-Feb-2013
Cell Host & MicrobeUNC researchers discover gene that suppresses herpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus hide within the worldwide human population. While dormant in the vast majority of those infected, these active herpesviruses can develop into several forms of cancer. In an effort to understand and eventually develop treatments for these viruses, researchers at the University of North Carolina have identified a family of human genes known as Tousled-like kinases that play a key role in the suppression and activation of these viruses.
National Institutes of Health, UNC Lineberger
Contact: William Davis
Public Release: 13-Feb-2013
Annals of OncologyCopper depletion therapy keeps high-risk triple-negative breast cancer at bay An anti-copper drug compound that disables the ability of bone marrow cells from setting up a "home" in organs to receive and nurture migrating cancer tumor cells has shown surprising benefit in one of the most difficult-to-treat forms of cancer -- high-risk triple-negative breast cancer.
Anne Moore Breast Cancer Research Fund, Stephen and Madeline Anbinder Foundation
Contact: Lauren Woods
Public Release: 13-Feb-2013
OncologistResearchers discover biological diversity in triple-negative breast cancer A team lead by Charles Perou, Ph.D., UNC Lineberger Comprehensive Cancer Center, examined more than 1,700 breast tumors, including 412 triple negative breast cancers, and concluded that triple-negative cancers and basal-like breast cancers should not be considered a single type.
National Institutes of Health, NIH/ National Cancer Institute, Breast Cancer Research Foundation, Sociedad Espanola de Oncología Medica
Contact: William Davis
Public Release: 13-Feb-2013
Cancer ResearchProtein central to cancer stem cell formation provides new potential target Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development. Contact: Scott Merville
Public Release: 13-Feb-2013
Journal of Pediatric Oncology NursingTube versus IV feeding in malnourished pediatric cancer patients About 60 percent of pediatric cancer patients experience malnourishment during treatment. At that point, patients and families have a choice: tube feeding or IV nutrition supplement. Which would you choose? A study published this week in the Journal of Pediatric Oncology Nursing shows that families' perceptions, especially of the discomfort of tube feeding, leads to choosing IV over tube – despite the fact that tube feeding is usually the better choice, associated with better gut function and lower rates of infection.
Rebecca Slye Endowment Grant
Contact: Garth Sundem
Public Release: 13-Feb-2013
New England Journal of MedicineDrug shown to reverse radioiodine resistance in some advanced thyroid cancers Memorial Sloan-Kettering Cancer Center researchers have found that the investigational drug selumetinib shuts down the signaling of genetic mutations that prevent some patients' thyroid cancer tumors from absorbing radioiodine, the most effective treatment for the disease. Contact: Caitlin Hool
Public Release: 13-Feb-2013
Journal of Clinical OncologyCleveland Clinic develops clinical screening program for no.1 genetic cause of colon cancer Cleveland Clinic develops clinical screening program for the number one genetic cause of colon cancer. Eight-year study addresses Lynch syndrome. Contact: Laura Ambro
Public Release: 13-Feb-2013
Journal of Clinical InvestigationKey molecule suppresses growth of cancerous liver tumors, Mayo study finds A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study has found. Its name is IQGAP1, and when the molecule is active in the cells that surround a tumor cell, this "tumor microenvironment" becomes less hospitable to cancer growth. When the molecule is deficient, cancer thrives.
National Institutes of Health
Contact: Joe Dangor
Public Release: 12-Feb-2013
Journal of Clinical OncologyStudy shows that problem-solving training helps mothers cope with child's cancer diagnosis A multi-site clinical trial of BRIGHT Ideas problem-solving training shows durable benefits in mothers of children diagnosed with cancer. Study published in Journal of Clinical Oncology. Materials available for download and use!
NIH/National Cancer Institute
Contact: Garth Sundem
Public Release: 12-Feb-2013
2013 Genitourinary Cancers SymposiumResearch from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors Research on promising new therapies and data on the relative benefits of established treatments for genitourinary cancers were released today, in advance of the fourth annual Genitourinary Cancers Symposium, being held Feb. 14-16, 2013, at the Rosen Shingle Creek in Orlando, FL. Contact: Kelly Baldwin
Public Release: 12-Feb-2013
Genes and DevelopmentMolecular master switch for pancreatic cancer identified, potential predictor of treatment outcome A recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammation. The Penn team profiled gene expression of mouse pancreatic ductal and duct-like cells from different states -- embryonic development, acute pancreatitis and K-ras mutation-driven carcinogenesis -- to find the molecular regulation of these processes.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases, National Pancreas Foundation
Contact: Karen Kreeger
Public Release: 12-Feb-2013
Cancer DiscoveryEmerging cancer drugs may drive bone tumors Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis.
National Institutes of Health, and others
Contact: Julia Evangelou Strait
Public Release: 12-Feb-2013
Experimental and Clinical PsychopharmacologyUTHealth: Alcohol consumption may be in response to smoking cessation New findings by researchers at the University of Texas Health Science Center at Houston School of Public Health may help identify situations in which smokers who are trying to quit are at a higher risk of relapse.
NIH/National Cancer Institute, American Cancer Society
Contact: Stephanie Logue
Public Release: 12-Feb-2013
Journal of American Chemical SocietyDetecting cocaine 'naturally' Since the beginning of time, living organisms have developed ingenious mechanisms to monitor their environment. As part of an international study, a team of researchers has adapted some of these natural mechanisms to detect specific molecules such as cocaine more accurately and quickly. Their work may greatly facilitate the rapid screening -- less than five minutes -- of many drugs, infectious diseases, and cancers.
Italian Ministry of University and Research, Bill & Melinda Gates Foundation, and others
Contact: Julie Gazaille
Showing releases 1126-1150 out of 1216. << < 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
 |
||||
|
|
 |
|